BusinessPuerto Rican Alzheimer’s Patients to Be First in U.S. to Obtain Cannabis-Based ReliefBy Nasdaq OMXMar 26, 2018, 1:44 PM UTC
BusinessIndia Globalization Capital Provides Update on Hyalolex for Alzheimer’s Commercialization StrategyBy Nasdaq OMXDec 14, 2017, 1:01 PM UTC
BusinessIndia Globalization Capital Reports Second Quarter 2018 Financial Results and Operational HighlightsBy Nasdaq OMXNov 20, 2017, 1:01 PM UTC
BusinessIGC Prepares a Liquid Delivery Formulation of IGC-AD1 for Alzheimer’s Based on Novel In Vitro DataBy Nasdaq OMXOct 4, 2017, 12:00 PM UTC
BusinessFutureWorld Corp (FWDG) Unveils Cannabis Industry’s First Ever CrowdEngine Funding Platform for Sophisticated Investors & Exceptional Companies Looking for Deals & FundingBy Nasdaq OMXSep 12, 2017, 12:01 PM UTC
BusinessIGC’s Drug Candidate for Alzheimer’s Potentially Presents New Molecular Pathway for THC to Inhibit Aβ40 ProductionBy Nasdaq OMXSep 11, 2017, 12:00 PM UTC
BusinessOpportunities galore for the evolving legal marijuana market segments in the U.S.By Nasdaq OMXJun 15, 2017, 7:45 PM UTC
BusinessIGC Acquires Exclusive Rights to THC-based treatment for Alzheimer’s DiseaseBy Nasdaq OMXJun 12, 2017, 11:36 AM UTC
